Manville R, Foglia L, Yoshimura R, Hogenkamp D, Nguyen A, Yu A
Proc Natl Acad Sci U S A. 2025; 122(2):e2411816122.
PMID: 39793113
PMC: 11745346.
DOI: 10.1073/pnas.2411816122.
Singh V, Auerbach D
Epilepsia. 2024; 65(9):2537-2552.
PMID: 39087855
PMC: 11702590.
DOI: 10.1111/epi.18066.
Servettini I, Talani G, Megaro A, Setzu M, Biggio F, Briffa M
Proc Natl Acad Sci U S A. 2023; 120(31):e2207978120.
PMID: 37487086
PMC: 10401004.
DOI: 10.1073/pnas.2207978120.
Manville R, Freites J, Sidlow R, Tobias D, Abbott G
Nat Commun. 2023; 14(1):3281.
PMID: 37280215
PMC: 10244465.
DOI: 10.1038/s41467-023-38834-6.
Paulhus K, Glasscock E
Int J Mol Sci. 2023; 24(10).
PMID: 37240170
PMC: 10219020.
DOI: 10.3390/ijms24108826.
Involvement of the Peripheral Nervous System in Episodic Ataxias.
Kozminski W, Pera J
Biomedicines. 2020; 8(11).
PMID: 33105744
PMC: 7690566.
DOI: 10.3390/biomedicines8110448.
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.
DAdamo M, Liantonio A, Rolland J, Pessia M, Imbrici P
Int J Mol Sci. 2020; 21(8).
PMID: 32331416
PMC: 7215777.
DOI: 10.3390/ijms21082935.
Clinical Spectrum of Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.
Paulhus K, Ammerman L, Glasscock E
Int J Mol Sci. 2020; 21(8).
PMID: 32316562
PMC: 7215408.
DOI: 10.3390/ijms21082802.
Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia.
Du X, Carvalho-de-Souza J, Wei C, Carrasquel-Ursulaez W, Lorenzo Y, Gonzalez N
Proc Natl Acad Sci U S A. 2020; 117(11):6023-6034.
PMID: 32132200
PMC: 7084159.
DOI: 10.1073/pnas.1920008117.
Identification of a New Mutation Underlying Regressive Episodic Ataxia Type I.
Karalok Z, Megaro A, Cenciarini M, Guven A, Hasan S, Taskin B
Front Neurol. 2018; 9:587.
PMID: 30140249
PMC: 6094999.
DOI: 10.3389/fneur.2018.00587.
New insights into the pathogenesis and therapeutics of episodic ataxia type 1.
DAdamo M, Hasan S, Guglielmi L, Servettini I, Cenciarini M, Catacuzzeno L
Front Cell Neurosci. 2015; 9:317.
PMID: 26347608
PMC: 4541215.
DOI: 10.3389/fncel.2015.00317.
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels.
Miceli F, Soldovieri M, Ambrosino P, De Maria M, Manocchio L, Medoro A
Front Cell Neurosci. 2015; 9:259.
PMID: 26236192
PMC: 4502356.
DOI: 10.3389/fncel.2015.00259.
Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.
Duarri A, Lin M, Fokkens M, Meijer M, Smeets C, Nibbeling E
Cell Mol Life Sci. 2015; 72(17):3387-99.
PMID: 25854634
PMC: 4531139.
DOI: 10.1007/s00018-015-1894-2.
Mutational consequences of aberrant ion channels in neurological disorders.
Kumar D, Ambasta R, Kumar P
J Membr Biol. 2014; 247(11):1083-127.
PMID: 25119057
DOI: 10.1007/s00232-014-9716-2.
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.
Graves T, Cha Y, Hahn A, Barohn R, Salajegheh M, Griggs R
Brain. 2014; 137(Pt 4):1009-18.
PMID: 24578548
PMC: 3959554.
DOI: 10.1093/brain/awu012.
Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.
Shah N, Aizenman E
Transl Stroke Res. 2013; 5(1):38-58.
PMID: 24323720
PMC: 3946373.
DOI: 10.1007/s12975-013-0297-7.
Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.
Tomlinson S, Tan S, Kullmann D, Griggs R, Burke D, Hanna M
Brain. 2010; 133(Pt 12):3530-40.
PMID: 21106501
PMC: 2995887.
DOI: 10.1093/brain/awq318.
Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.
Heeroma J, Henneberger C, Rajakulendran S, Hanna M, Schorge S, Kullmann D
Dis Model Mech. 2009; 2(11-12):612-9.
PMID: 19779067
PMC: 2773728.
DOI: 10.1242/dmm.003582.
Episodic ataxia type 1: a neuronal potassium channelopathy.
Rajakulendran S, Schorge S, Kullmann D, Hanna M
Neurotherapeutics. 2007; 4(2):258-66.
PMID: 17395136
DOI: 10.1016/j.nurt.2007.01.010.
Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.
Chen H, von Hehn C, Kaczmarek L, Ment L, Pober B, Hisama F
Neurogenetics. 2006; 8(2):131-5.
PMID: 17136396
PMC: 1820748.
DOI: 10.1007/s10048-006-0071-z.